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Abstract
Background: It has long been recognized that there is an association between enlarged head circumference (HC)
and autism spectrum disorder (ASD), but the genetics of HC in ASD is not well understood. In order to investigate
the genetic underpinning of HC in ASD, we undertook a genome-wide linkage study of HC followed by linkage
signal targeted association among a sample of 67 extended pedigrees with ASD.
Methods: HC measurements on members of 67 multiplex ASD extended pedigrees were used as a quantitative
trait in a genome-wide linkage analysis. The Illumina 6K SNP linkage panel was used, and analyses were carried out
using the SOLAR implemented variance components model. Loci identified in this way formed the target for
subsequent association analysis using the Illumina OmniExpress chip and imputed genotypes. A modification of the
qTDT was used as implemented in SOLAR.
Results: We identified a linkage signal spanning 6p21.31 to 6p22.2 (maximum LOD = 3.4). Although targeted
association did not find evidence of association with any SNP overall, in one family with the strongest evidence of
linkage, there was evidence for association (rs17586672, p = 1.72E−07).
Conclusions: Although this region does not overlap with ASD linkage signals in these same samples, it has been
associated with other psychiatric risk, including ADHD, developmental dyslexia, schizophrenia, specific language
impairment, and juvenile bipolar disorder. The genome-wide significant linkage signal represents the first reported
observation of a potential quantitative trait locus for HC in ASD and may be relevant in the context of complex
multivariate risk likely leading to ASD.
Keywords: Autism spectrum disorder (ASD), Head circumference (HC), Genome-wide linkage, Genetic association

Background
Autism spectrum disorder (ASD) is characterized by
phenotypic and genetic heterogeneity, and an association
with abnormal brain growth has long been recognized.
For example, there is an association between ASD and
specific Mendelian disorders, such as Rett’s syndrome
(microcephaly), a microdeletion syndrome at 16p11.2
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(macrocephaly) [1], and copy number variation (CNV)
in genes associated with brain growth, such as PTEN
(macrocephaly) [2]. Moreover, increased head circumference (HC) is a consistent and replicated finding among
individuals with ASD, with ~20% labeled macrocephalic
given norms for sex, age, and body size [3–5]. Crosssectional studies have identified significantly larger HC
among individuals with ASD, and this is true for both
children and adults [3, 5]. In addition, when longitudinal
data are examined, accelerated head growth during the
early months of development is observed among individuals who subsequently develop ASD [4] and there is also
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some evidence that larger head size is associated with
greater ASD symptom severity [6].
Beyond the known rare single gene associations for
ASD, little is known about the genetic architecture of
HC variance in ASD. For the population more generally,
evidence from genome-wide association (GWA) studies
indicates loci at 12q15 and 12q24 are associated with infant (6–18 months) HC [7] while variants at 6q22 and
17q21 are associated with intracranial volume measured
by MRI in older adults [8]. Common variants within
these associated regions tag genes of potential significance to brain growth, such as HMGA2 (12q15) and
CRHR1 (17q21). None of these loci, however, overlap
previously identified ASD genes.
Understanding the genetic architecture of abnormal
brain growth in ASD may shed light on the pathogenesis
of ASD, as well as identifying new ASD genes and those
involved in brain development more generally. With this
in mind, we examined the genetic underpinning of HC
using QTL-based genome-wide linkage combined with
targeted association analysis. HC has already been identified as a highly heritable trait [6], and so we anticipated
that performing genome-wide linkage of HC would be a
powerful approach to narrow the genomic search space.
We hypothesized that HC loci would overlap linkage signals for ASD in the same families and that family-based
quantitative trait association targeted to linkage regions
would fine map the identified signal(s).

Project (AGP) provided an opportunity for replication.
This consortium of international researchers comprised
scientists from ~50 centers in North America and
Europe (the ‘AGP sample’). From the complete sample,
subjects from the Utah discovery sample were excluded,
and of the remaining families, only those with available
HC data were included. This final sample comprised 973
families among which 1041 individuals (621 individuals
with ASD and 420 unaffected relatives) had both HC
and genotype data. For each site, diagnosis was based on
the ADI-R or ADOS or best clinical estimate as described previously [10]. AGP data were collected with
approval from institutional review boards of all participating centers [10].

Methods

Genotyping for linkage

Discovery sample

Families were part of the Utah collection of multiplex
ASD families (the ‘Utah sample’ [9]). Subjects were 1552
members (249 with ASD, 1303 relatives of unknown
ASD status) of 67 families having at least two family
members with ASD. The families comprised 20 large extended families of 6–9 generations, 6 moderately sized
families of 4–5 generations and 41 smaller families of 2–
3 generations. In total, 667 participants, comprising
those with (N = 198) or without (N = 469) ASD, had data
on HC from at least one time point, as well as height
and genotypic data. Diagnoses of ASD were made according to a combination of ADI-R and ADOS assessments [9]. This study has ongoing approval from the
University of Utah institutional review board (IRB). All
adults participating in the research signed informed consent documents. All subjects under the age of 18 years
signed assent documents, and their parents or guardians
signed parental permission. These documents were approved by the University of Utah IRB.

Utah sample: Genotyping was provided by the Center
for Inherited Disease Research (CIDR) using the
Illumina 6K SNP linkage panel. Methods and quality
control procedures have been described in detail previously [9]. After quality control, genotypes were available
on 6044 SNPs. SNPs in linkage disequilibrium were filtered using PLINK v1.07 [11], with a pairwise r2 threshold of 0.5 (i.e. a variance inflation factor, as defined in
PLINK, of 1.5) which removed 1207 SNPs. As part of
the validation procedure, 115 SNPs with a minor allele
frequency (MAF) of <0.1 were removed and 4 SNPs that
were not in Hardy-Weinberg Equilibrium (HWE, p < 0.05)
using genotype data from founders. The total number of
SNPs left at this stage was 4718. AGP sample: Genotypes
were obtained using the Affymetrix (Santa Clara, CA) 10K
SNP arrays at the Translational Genomics Research Institute. A total of 5371 tagSNPs were selected having removed those in strong linkage equilibrium with each
other (maximum D’ = 0.6), those not in HWE, and those
with MAF < 0.1 were also removed [12].

Replication sample

Genotyping for association

One thousand three hundred ninety-seven multiplex
ASD families that were part of the Autism Genome

We obtained additional Illumina OmniExpress (OE) data
on 335 members from 14 of the 67 Utah families. These

Phenotype

In both samples, HC was measured from the occipital
protuberance to the forehead using standardized procedure. If multiple measurements were available on any one
individual, one was selected randomly. Reliability of HC
measurements was established across raters at the Utah
site; intraclass correlations for reliability measurements
were >0.95. Additionally, reliability was established
across sites participating in AGP (within- and across-site
intraclass correlations were >0.90). Data were visualized
graphically to identify the distributional characteristics
and presence of potential outliers. Height was measured
on all participants using a stadiometer.
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14 families comprise most of the extended families having three or more generations. In total, 716,503 SNPs
passed QC (removed: SNPs with HWE p < 0.05, samples
with <95% call rate, SNPs with <97% call rate), of which
2647 were shared with the 6K chip. As not all members
of families had OE genotypes, but most did have the
sparser set of 6K SNPs, we used a family imputation approach as implemented in GIGI (v1.06.1) [13] to impute
the expected allele dosage (i.e. 0, 1 or 2) of each OE SNP
among the non-genotyped individuals of the 14 families.
GIGI uses the inheritance information for the complete
family as inferred from the 6K chip in addition to the
OE chip to calculate these genotype probabilities; as
such, it does not require a population sample. As per the
requirements of SOLAR (see below), only genotypes
where both alleles were called with >80% certainty were
included. If one or both alleles were called with <80%
certainty, both were excluded and the genotype was labeled missing.
Investigation of patterns of family-specific variant
segregation using Illumina HumanCoreExome chip

Many individuals from the Utah sample (N = 505) were
also genotyped using the Illumina HumanCoreExome
chip, providing dense SNP genotypes across the genome.
Analysis

Phenotype: The distributional properties of HC adjusted
for sex, age, age2 and height was examined by way of
histogram and QQplot. We also performed randomeffects modeling to investigate inter-pedigree HC variation. Pedigree-specific residuals and their 95% confidence intervals were estimated and displayed graphically
using a caterpillar plot. All analyses were performed
using R v3.2.2 [14]. Linkage: For the discovery sample,
the genetic map provided by CIDR was used, which is
based on the deCODE genetic map [15]. Base pair
positions were obtained from the March 2006 human
reference sequence (hg18) assembly. For the replication sample, genetic and physical maps were built
using the Gene Map Interpolator (https://watson.hgen.pitt.edu/register/docs/gmi.html) in conjunction with
genome build hg38. QTL analysis on LD pruned SNP data
was then performed separately for each dataset, and then
using the datasets combined, using SOLAR v7.6.4 [16],
with data formatted using MEGA2 v4.8.0 [17]. SOLAR
implements a variance components linkage approach,
with the trait first screened for normality and kurtosis,
followed by the calculation of heritability and the impact
(significance level) of pre-specified covariates. The variance components linkage approach is based on the classic
quantitative genetics model in which phenotype is influenced by genes and environment. The genetic component
is decomposed into additive and dominant genetic effects
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at the trait locus, modeled using IBD sharing, along with
background polygenic effects. In this way, the covariate
matrix of the trait can then be expressed conditionally on
IBD sharing at the locus and the parameters estimated
using maximum-likelihood methods. In our analysis, HC
was specified as the quantitative trait, with sex, age, age2
and height as covariates. Multipoint estimates of IBD
sharing using MCMC methods were computed using
LOKI v2.3 [18] and then imported into SOLAR for multipoint scanning at intervals of 2 cM and with regions demonstrating a LOD of >0.5 more finely mapped to intervals
of 1 cM. Model parameters are estimated in SOLAR using
maximum likelihood methods assuming multivariate normality, with significance calculated using a likelihood ratio
test, and typical LOD scores reported. Where there was
violation of normality, empirical LOD adjustments were
performed using the lodadj option. This simulates a fully
informative marker unlinked to the trait from which IBDs
are calculated and LODs computed during 10,000 replications. In this way, a factor score is generated by which all
LODs are then automatically adjusted. SOLAR only allows
multipoint scanning of autosomes, and therefore, twopoint results are reported for the X chromosome. Targeted
association: The qTLD test [19], as implemented in
SOLAR [16], is a modification of the qTDT, a variance
components-based association test in which association is
modeled as a mean effect of genotype scores decomposed
into within- and between-pair components. The withinpair component is not influenced by possible underlying
population stratification, and a likelihood ratio test can be
conducted allowing the within-pair co-efficient to be freely
estimated versus being fixed at 0 (the null model). As an
extension of this model, Havill and colleagues proposed
the qTLD test [19]. In this model, founder genotypes are
included in the ‘within-family’ rather than ‘between-family’
component, essentially eliminating the need to decompose
the genotype scores without loss of power. However, this
approach is only applicable in the absence of population
stratification (a stratification metric is provided). Like the
qTDT (on which it is largely based), qTLD is a direct test
of linkage disequilibrium whose type 1 error rate is not inflated by the presence of linkage.
In our analysis, HC was specified as the trait of interest. Targeted association was performed for a region defined as -1-LOD around signals that were significantly
indicative of linkage as indicated by a genome-wide
LOD score of >3.3. We first ran the analysis for the
complete sample and then again using only the family
contributing most strongly to the linkage signal. As our
association analyses were not genome-wide, we calculated
level of significance using the conservative Bonferroni
adjustment (p = 0.05/number of SNPs). Investigation of
pattern of family-specific variant segregation: Illumina
HumanCoreExome data were formatted as a vcf file and
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imported into GEMINI (v0.18) [20] for analysis. Rare, exonic SNP variants located within linkage signals and that
were shared among members of the family with head size
>1.88 SD from the mean were identified and annotated
using methods implemented in GEMINI.

Results
Descriptive

The 67 Utah pedigrees comprised 667 individuals who
had both genotype and phenotype information (Table 1
and Additional file 1: Table S1). Of these, 198 were diagnosed with ASD and 469 were non-diagnosed (considered phenotype unknown for this analysis). The male-tofemale ratio of ASD cases was 5.5:1, consistent with
population figures. We also investigated the distribution
of HC in a pedigree-by-pedigree manner using a
random-effects model. As expected, some families segregated large or small heads and the majority of families
straddled the standardized mean score (Additional file 1:
Figure S1).
Linkage

We conducted linkage analyses with sex, age, age2 and
height as covariates. A heritability of 66.0% was demonstrated, with all covariates in this model accounting for
73.2% of trait variance. Chromosome-by-chromosome
plots are presented in the supplementary text (Additional
file 1: Figure S2). Our genome-wide linkage scan of the
Utah extended pedigree sample revealed a single complex
signal with two peaks consistent with significant evidence
of linkage, one at 6p21.31 (LOD = 3.4) and the other
at 6p22.2 (LOD = 3.3) (Fig. 1 and Additional file 1:
Figure S2). We also examined family specific contributions
to the largest linkage signal at 6p21.31, with the results indicating that one family (referred to hereafter as Family 1)
attained a family-specific LOD score of 1.5, with all other
families displaying marginal or negative linkage. Our twopoint analysis of the X chromosome did not identify any
signals (data not shown).
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We were interested in whether we could replicate this
signal in an independent sample. We therefore investigated linkage for HC in the AGP dataset. This sample
has previously been well described [10], and their
characteristics are summarized in Table 1 and Additional
file 1: Table S1. Our scan identified a signal on chromosome 1 (LOD = 2.7 at 1q25.3, Additional file 1: Figure S3).
Again, two-point analysis of the X chromosome did
not identify any signals (data not shown). Finally, we
combined the non-overlapping Utah and AGP samples into a larger sample and performed genome-wide
linkage. The results are summarized in the supplementary text (Additional file 1: Figure S4). In brief,
signals were evident on both chromosomes 1 (LOD = 2.9
at 1q25.3) and 6 (LOD = 2.4 at 6p22.3 and LOD = 2.4 at
6p21.3). Once again, no signals were observed on the X
chromosome.
Targeted association

Our linkage scans identified only two significant signals.
These were identified for the Utah families and were
close together in a region on chromosome 6. We therefore targeted our quantitative trait association analysis to
this region, using the densely genotyped Utah families as
described in the methods. Specifically, we used a -1LOD margin on both sides of the linkage signals. The
two signals were close enough to result in a single region
that spanned 6p21.31 to 6p22.3 (co-ordinates 20,819,976
to 39,796,910 on hg19). This region comprised 10,817
OE SNPs, and we therefore set our Bonferroni corrected
p value at 5E−06.
No evidence of association was observed for HC using
the complete sample (Additional file 1: Figure S5). Two
SNPs located at 6p22.2 had p values of 4.3E−05
(rs9295654) and 6.9E−05 (rs2690129). Other SNPs with
marginal evidence of association are summarized in
Table 2. We also carried out targeted association for the
one family (‘Family 1’, Additional file 1: Figure S6) showing the strongest evidence of linkage to this region. One

Table 1 Characteristics of Utah and AGP samples
Utah
Age, years: mean(SD)

AGP
a

ASD (N = 198)

Non ASD (N = 469)

All (N = 667)

ASD (N = 621)

Non-ASDa (N = 420)

All (N = 1041)

13.8 (12.4)

36.06 (19.75)

29.49 (20.58)

8.9 (4.7)

32.8 (15.1)

18.52 (15.6)

Sex, %male; %female

84.8%; 15.2%

46.5%; 53.5%

57.9%; 42.1%

81.1%; 18.9%

47.1%; 52.9%

67.4%; 32.6%

Ethnicity b

85.9:0:0:0:14.1

86.5:0:0:0.8:12.7

86.6:0:0: 0.6: 12.8

64.5:0.5:0.5:6.4:28.1

16.2:0.1:0.5:0:82.5

41.9:0.3:0.5:3.4:53.5

HC, cm mean (SD)

54.0 (3.0)

55.7 (2.8)

55.2 (2.9)

54.0 (1.8)

57.1 (2.1)

55.5 (2.9)

Height, cm mean (SD)

141.0 (28.3)

165.3 (22.3)

158.2 (26.6)

134.6 (20.2)

169.0 (9.8)

150.8 (25.6)

Residualized (internal) HCc
mean (SD)

0.0 (1.9)

0.0 (1.7)

0.0 (1.8)

0.0 (1.9)

0.0 (2.0)

0.0 (2.0)

a

Non ASD comprise family members who have generally not undergone clinical evaluation for ASD
Ethnicity (%): White:Black:Asian:Other:Missing
c
Residualized HC generated by linear model covarying for effect of age, age2 and sex using the complete sample
b
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Fig. 1 Chromosome 6 linkage signal

SNP was significantly associated with residualized HC
(rs17586672, p = 1.72E−07, Additional file 1: Figure S7;
Table 2). Despite the known extensive LD in this region,
this intergenic SNP did not show strong LD with most
of the adjacent SNPs in this 19-Mb region.
Table 2 Lead SNP associations on chromosome 6
SNP

MAF REF/ALT Position (hg19) Stratificationa p value

Complete sample
rs849886

0.41 A/G

22,291,367

0.77

1.30E−04

rs9379751

0.39 A/G

25,292,214

0.31

1.09E−04

rs2690129

0.46 G/T

25,297,658

0.35

6.90E−05

rs9295654

0.3

A/G

25,312,755

0.61

4.30E−05

rs9467466

0.3

C/T

25,312,915

0.55

7.78E−05

rs17586672 0.17 C/T

23,941,746

0.79

1.72E−07

rs1277145

0.24 A/G

24,060,381

0.25

5.38E−07

rs529648

0.27 A/G

24,939,867

0.25

5.38E−07

rs6900224

0.16 C/T

25,437,986

0.6

3.65E−06

rs12211633 0.46 C/T

34,050,917

0.11

2.41E−06

Family 1

SNPs ordered by position
a
Stratification is calculated by calculating the likelihood ratio for a model
where between and within family genotype metrics are both estimated,
compared with a model where both metrics are held equal. The stratification
value given in the table is a p value in connection with this likelihood ratio
test (<0.05 indicating significant likelihood of stratification)

Investigation of the pattern of family-specific variant
segregation

Three variants were shared among the five members of
Family 1 with HC >1.88 SD from the mean. None were
exonic however. These included rs1076829 (MAF = 0.24,
three heterozygous and two homozygous for minor
allele) a DHX16 intronic variant and two intergenic
variants rs3115573 (MAF = 0.45, three heterozygous
and two homozygous for minor allele) and rs1367731
(MAF = 0.15, all five with heterozygous genotypes).

Discussion
The aim of this study was to identify genetic loci for HC
in families segregating ASD. In the Utah families, one
locus with two signals was identified with significant evidence of linkage to HC residualized for the effects of
sex, age, age2 and height. One family accounted for
much of the linkage evidence. These signals were neither
identified in our non-overlapping replication sample, nor
in the combined discovery and replication sample, although nearby ‘suggestive’ loci were identified. Additionally, in our replication sample, several other loci were
identified with ‘suggestive’ evidence of linkage.
By also carrying out linkage-signal targeted association,
we were also able to identify an allele of one SNP associated with HC in the one family driving the linkage signal.
This combination of linkage and targeted association is an
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attractive strategy for the identification of familial segregating genetic risk for complex disorders. Although we
also had the opportunity to examine allele sharing in this
family by way of available Illumina HumanCoreExome
data, only three SNPs demonstrated minor alleles segregating among individuals with HC > 1.88 SD from the
mean, and none were in coding regions.
None of the linkage signals in our study overlapped
the population-level GWAS association results for HC
at 18 months of age [7] or for intracranial volume during
late adulthood [8]. Of course, these analyses were on
population-level samples without ASD, the underlying
genetics of which may be very different from HC in
ASD. Moreover, our power to detect these associated regions using linkage analysis is likely very low.
Similarly, none of these linkage peaks overlapped those
demonstrated in previous studies of these same samples
using autism and related phenotypes [9, 21, 22]. One signal for the social responsiveness scale (SRS) was recorded at 6p22.1 (LOD = 2.36, using a qualitative defined
cut-off score and a recessive model of inheritance),
which does not overlap the HC signal from the current
analysis. No signal for SRS was observed on chromosome 1. Instead, the largest signals for all traits measured were on chromosomes 15, 13 and 7. At none of
these locations were any linkage signals for HC demonstrated. Considering the previously published AGP
genome-wide linkage analyses [10, 12], suggestive evidence for linkage was found for ASD as a discrete trait
on chromosome 11 and chromosomes 11 and 15 for
subsets defined by phrase speech delay and IQ > 69,
respectively.
The fact that our linkage signals did not overlap those
for ASD in the same samples needs some explanation, as
this does not support an etiological relationship between
HC and ASD in these families. On the one hand, much
variation in HC was seen from family to family, with
some families segregating larger heads. Among such
families, therefore, there may be a more intimate relationship between the aetiological factors for ASD and
head size. However, even for the most significantly
linked family, no overlap was seen for ASD and HC linkage signals. This does not, of course, rule out the possibility that more than one genetic mechanism, acting in
tandem, is involved in the expression of the ASD phenotype. For example, a combination of one locus, influencing brain size, and another, influencing some other
brain mechanism, could raise vulnerability to ASD. Additionally, power is low in both analysis, and so false negatives are highly likely.
Although 6p21.31 is a gene-rich region, our associated
SNP does not overlap any expressed or regulatory elements. The most proximal genes are NRSN1 and
DCDC2, and both are of potential interest. NRSN1 codes
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for a protein involved in nerve growth and has a possible
role in neurite extension [23]. Association has been
identified with ADHD [24]. Similarly, DCDC2 is a highly
brain expressed gene with a role in neuronal migration
[25] and with exonic variants demonstrating association
with developmental dyslexia [26]. The wider linked region is relatively broad and gene rich and includes the
MHC, which is associated with ASD [27], schizophrenia
[28] and specific language delay [29]. There is also evidence of linkage to juvenile bipolar disorder [30].
While confounding any simple explanation for the
possibility of shared genes underlying HC and ASD in
these families, the study does illustrate the potential utility of the family design in targeting genetics of complex
phenotypes, as well as the importance of considering a
family-by-family as well as pooled approach. The identification of linkage signals for HC also raises the ongoing
need to consider HC as a biomarker for brain growth
that may inform the search for genes and regulatory elements that harbor susceptibility to ASD and other developmental disorders of brain growth.

Conclusions
Head circumference, as an index of brain growth, was
found to be linked to a chromosomal region at 6p21.31
that neither overlaps with any previously identified ASD
loci, nor linkage signals for ASD and ASD-related phenotypes in these same families. This signal was found to
be principally driven by one family, and by further investigation of this family by way of linkage signal-targeted
association, a significant association signal was identified
near to NRSN1 and DCDC2; both genes are potential
candidates for brain growth. Head circumference is a
marker of brain growth and represents an important,
easily measurable trait for future studies of the genetics
of neurodevelopmental disorders.
Additional file
Additional file 1: Combined genome-wide linkage and targeted association analysis of head circumference in autism spectrum disorder families.
(PDF 1305 kb)
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